Amarillo, Texas -
AMARILLO -- Cardiology Center of Amarillo along with PharmaTex Research announced the beginning of a new clinical trial to test the safety and effectiveness of new pacemaker technology to withstand the negative forces of MRI technology when compared to traditional pacemakers.
The completed Phase A of the trial evaluated the safety of BIOTRONIKs current pacemaker systems during magnetic resonance imaging (MRI) scans excluding chest and thorax scan areas. Now Phase B of the trial will evaluate the same pacemaker system during MRI scans without exclusion zones.
Several million patients are currently implanted with pacemaker systems worldwide, and recent studies estimate that a sizeable portion of them will develop a clinical need for a MRI scan during their lifetimes.
Investigators have not released the name of the victim pending…
Potter County Memorial Stadium's future is in question now that…
11 hours ago